Search Ontology:
ChEBI

beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer

Term ID
CHEBI:140691
Synonyms
  • a globoside GalGb4Cer
  • beta-D-galactopyranosyl-(1->3)-2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->3)-alpha-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl-(1<->1')-ceramide
  • beta-D-galactosyl-(1->3)-N-acetyl-beta-D-galactosaminyl-(1->3)-alpha-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-Cer
  • beta-D-Galp-(1->3)-beta-D-GalpNAc-(1->3)-alpha-D-Galp-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta-Cer
  • Galbeta1-3GalNAcbeta1-3Galalpha1-4Galbeta1-4Glcbeta1-1Cer
  • Galbeta1->3GalNAcbeta1->3Galalpha1->4Galbeta1->4Glcbeta1->1Cer
  • GalGbOse4Cer
  • GL-X
  • SSEA-3 antigen
  • SSEA-3a
  • SSEA3
  • stage-specific embryonic antigen 3
  • stage-specific embryonic antigen-3
Definition
A glycopentaosylceramide having β-D-galactosyl-(1→3)-N-acetyl-β-D-galactosaminyl-(1→3)-α-D-galactosyl-(1→4)-β-D-galactosyl-(1→4)-β-D-glucosyl as the glycopentaosyl component. It is a glycosphingolipid that has previously been used to identify cells with stem cell-like, multipotent, and pluripotent characteristics.
References
  • lipidmaps:LMSP0502AE00
  • pubmed:10837462
  • pubmed:16643871
  • pubmed:18685093
  • pubmed:2146256
  • pubmed:23175153
  • pubmed:23441574
  • pubmed:23514702
  • pubmed:23668861
  • pubmed:25561682
  • pubmed:26677875
  • pubmed:2885313
  • pubmed:30271856
  • pubmed:30997834
  • pubmed:31817926
  • pubmed:31936807
  • pubmed:32525407
  • pubmed:32684574
  • pubmed:6143701
  • pubmed:6863318
  • pubmed:7595524
  • pubmed:7983056
  • wikipedia.en:Stage_specific_embryonic_antigen_3
Ontology
ChEBI  ( EBI )
Relationships
Phenotype
Phenotype resulting from beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Phenotype where environments contain beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Phenotype modified by environments containing beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Phenotype affecting beta-D-Gal-(1->3)-beta-D-GalNAc-(1->3)-alpha-D-Gal-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-Cer
Human Disease Model